Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 45: 1018-1025, 1999;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (46)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shi, Q.
Right arrow Articles by Laurino, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shi, Q.
Right arrow Articles by Laurino, J. P.
Related Collections
Right arrow Proteomics and Protein Markers
(Clinical Chemistry. 1999;45:1018-1025.)
© 1999 American Association for Clinical Chemistry, Inc.

Articles

Degradation of Cardiac Troponin I in Serum Complicates Comparisons of Cardiac Troponin I Assays

Qinwei Shia, Mingfu Ling, Xiaochen Zhang, Minyuan Zhang, Lilly Kadijevic, Shigui Liu and Joseph P. Laurino

Spectral Diagnostics Inc., 135-2 The West Mall, Toronto, Ontario, Canada M9C 1C2.
a Author for correspondence. Fax 416 626-7383; e-mail qshi{at}ica.net

Background: Up to a 20-fold variation in serum cardiac troponin I (cTnI) concentration may be observed for a given patient sample with different analytical methods. Because more limited variation is seen for control materials and for purified cTnI, we explored the possibility that cTnI was present in altered forms in serum.

Methods: We used four recombinantly engineered cTnI fragments to study the regions of cTnI recognized by the Stratus®, Opus®, and ACCESS® immunoassays. The stability of these regions in serum was analyzed with Western blot.

Results: The measurement of several control materials and different forms of purified cTnI using selected commercial assays demonstrated five- to ninefold variation. Both the Stratus and Opus assays recognized the N-terminal portion (NTP) of cTnI, whereas the ACCESS assay recognized the C-terminal portion (CTP) of cTnI. Incubation of recombinant cTnI in normal human serum produced a marked decrease in cTnI concentration as determined with the ACCESS, but not the Stratus, immunoassay. Western blot analysis of the same samples using cTnI NTP- and CTP-specific antibodies demonstrated preferential degradation of the CTP of cTnI.

Conclusions: The availability of serum cTnI epitopes is markedly affected by the extent of ligand degradation. The N-terminal half of the cTnI molecule was found to be the most stable region in human serum. Differential degradation of cTnI is a key factor in assay-to-assay variation.© 1999 American Association for Clinical Chemistry




The following articles in journals at HighWire Press have cited this article:


Home page
 Asian Cardiovasc. Thorac. Ann.Home page
D. Abramov, M. Abu-Tailakh, M. Frieger, A. Ganiel, D. Tuvbin, and A. Wolak
Plasma Troponin Levels After Cardiac Surgery vs After Myocardial Infarction
Asian Cardiovasc Thorac Ann, December 1, 2006; 14(6): 530 - 535.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
R. Labugger, J. A. Simpson, M. Quick, H. A. Brown, C. E. Collier, I. Neverova, and J. E. Van Eyk
Strategy for Analysis of Cardiac Troponins in Biological Samples with a Combination of Affinity Chromatography and Mass Spectrometry
Clin. Chem., June 1, 2003; 49(6): 873 - 879.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
D. Uettwiller-Geiger, A. H.B. Wu, F. S. Apple, A. W. Jevans, P. Venge, M. D. Olson, C. Darte, D. L. Woodrum, S. Roberts, and S. Chan
Multicenter Evaluation of an Automated Assay for Troponin I
Clin. Chem., June 1, 2002; 48(6): 869 - 876.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
P. Venge, B. Lindahl, and L. Wallentin
New Generation Cardiac Troponin I Assay for the Access Immunoassay System
Clin. Chem., May 1, 2001; 47(5): 959 - 961.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
A. Lavoinne, B. Cauliez, H. Eltchaninoff, R. Koning, and A. Cribier
Analytical and Clinical Performance of the Immulite Cardiac Troponin I Assay
Clin. Chem., December 1, 2000; 46(12): 1989 - 1990.
[Full Text] [PDF]

Home page
 CirculationHome page
A. S. Jaffe, J. Ravkilde, R. Roberts, U. Naslund, F. S. Apple, M. Galvani, and H. Katus
It's Time for a Change to a Troponin Standard
Circulation, September 12, 2000; 102(11): 1216 - 1220.
[Full Text] [PDF]

Home page
 CirculationHome page
R. Labugger, L. Organ, C. Collier, D. Atar, and J. E. Van Eyk
Extensive Troponin I and T Modification Detected in Serum From Patients With Acute Myocardial Infarction
Circulation, September 12, 2000; 102(11): 1221 - 1226.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
D. A. Morrow, N. Rifai, M. J. Tanasijevic, D. R. Wybenga, J. A. de Lemos, and E. M. Antman
Clinical Efficacy of Three Assays for Cardiac Troponin I for Risk Stratification in Acute Coronary Syndromes: A Thrombolysis In Myocardial Infarction (TIMI) 11B Substudy
Clin. Chem., April 1, 2000; 46(4): 453 - 460.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
D. S. Ooi, P. A. Isotalo, and J. P. Veinot
Correlation of Antemortem Serum Creatine Kinase, Creatine Kinase-MB, Troponin I, and Troponin T with Cardiac Pathology
Clin. Chem., March 1, 2000; 46(3): 338 - 344.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
D. H. Wilson, D. M. Laird, C. M. Forsythe, T. T. Biegalski, A. L. Keller, and R. J. Herrmann
Antibody Selection for the Abbott AxSYM Troponin I Assay
Clin. Chem., December 1, 1999; 45(12): 2293 - 2294.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
S. Liu, M. Y. Zhang, Q. Song, X. Zhang, L. Kadijevic, and Q. Shi
Extra Leader Sequence Affects Immunoactivity of Cardiac Troponin I
Clin. Chem., August 1, 1999; 45(8): 1300 - 1302.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American Association for Clinical Chemistry.